全文获取类型
收费全文 | 26553篇 |
免费 | 1950篇 |
国内免费 | 166篇 |
专业分类
耳鼻咽喉 | 219篇 |
儿科学 | 641篇 |
妇产科学 | 410篇 |
基础医学 | 3557篇 |
口腔科学 | 364篇 |
临床医学 | 2895篇 |
内科学 | 5996篇 |
皮肤病学 | 335篇 |
神经病学 | 2324篇 |
特种医学 | 1079篇 |
外科学 | 4287篇 |
综合类 | 305篇 |
现状与发展 | 1篇 |
一般理论 | 25篇 |
预防医学 | 1908篇 |
眼科学 | 417篇 |
药学 | 1813篇 |
中国医学 | 44篇 |
肿瘤学 | 2049篇 |
出版年
2023年 | 259篇 |
2022年 | 454篇 |
2021年 | 1002篇 |
2020年 | 515篇 |
2019年 | 813篇 |
2018年 | 928篇 |
2017年 | 654篇 |
2016年 | 670篇 |
2015年 | 771篇 |
2014年 | 1051篇 |
2013年 | 1328篇 |
2012年 | 2072篇 |
2011年 | 2091篇 |
2010年 | 1145篇 |
2009年 | 1006篇 |
2008年 | 1620篇 |
2007年 | 1653篇 |
2006年 | 1480篇 |
2005年 | 1427篇 |
2004年 | 1350篇 |
2003年 | 1253篇 |
2002年 | 1235篇 |
2001年 | 192篇 |
2000年 | 149篇 |
1999年 | 227篇 |
1998年 | 307篇 |
1997年 | 271篇 |
1996年 | 230篇 |
1995年 | 217篇 |
1994年 | 202篇 |
1993年 | 175篇 |
1992年 | 119篇 |
1991年 | 87篇 |
1990年 | 107篇 |
1989年 | 108篇 |
1988年 | 94篇 |
1987年 | 126篇 |
1986年 | 88篇 |
1985年 | 88篇 |
1984年 | 109篇 |
1983年 | 103篇 |
1982年 | 108篇 |
1981年 | 98篇 |
1980年 | 104篇 |
1979年 | 50篇 |
1978年 | 61篇 |
1977年 | 53篇 |
1976年 | 37篇 |
1975年 | 42篇 |
1973年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
Toxocariasis: a serological survey of blood donors in the Australian Capital Territory together with observations on the risks of infection 总被引:4,自引:0,他引:4
W L Nicholas A C Stewart J C Walker 《Transactions of the Royal Society of Tropical Medicine and Hygiene》1986,80(2):217-221
The sera from 660 healthy blood donors from Canberra were tested for antibodies to Toxocara canis by the ELISA test. The results were compared with those from patients with suspected or confirmed visceral larva migrans or ocular toxocariasis. Over 7% of Canberra sera showed elevated levels of antibody reacting with T. canis antigen. Sera from patients resident in Australia with other helminth parasites did not cross-react with T. canis antigen in our tests. However, studies of sera collected in several tropical countries with other parasitic infection, show that cross-reactions with other parasites are possible. The use of purified glycoprotein antigen does not alter the possibility of cross-reaction. Observations and experiments show that people in Canberra may be exposed to the infective eggs of T. canis. 相似文献
23.
A. Robert Spitzer Shalom Stahl David Yarnitsky Ernest W. Johnson John R. Wilson R. A. C. Hughes Stefania Morino Giovanni Antonini Kiyotoshi Kaneko Yoji Ohnishi Tetsushi Atsumi Isao Hozumi Tadashi Miyatake Tetsuo Furukawa James P. Knochel Ikuo Mineo Seiichiro Tarui Francis O. Walker Andrew J. Gitter Walter C. Stolov Nicholas J. Capozzoli 《Muscle & nerve》1996,19(4):531-538
24.
Miguel A. Rodriguez-Bigas MD Remedios B. Penetrante MD Lemuel Herrera MD Nicholas J. Petrelli MD 《Gastrointestinal endoscopy》1995,42(6)
Background: In familial adenomatous polyposis and juvenile polyposis, polyps can occur throughout the gastrointestinal tract.Methods: We report seven patients with familial adenomatous polyposis and two patients with juvenile polyposis who underwent small bowel enteroscopy at the time of exploratory celiotomy either for colectomy or other pathology.Results: Polyps in the jejunum and/or ileum were noted in five of nine (56%) patients at enteroscopy. In three of nine (33%) patients these polyps were adenomatous. Two of these patients had polyps in the jejunum and in the ileum, whereas one patient had jejunal adenomas alone. These polyps were from 3 mm to 30 mm in size. The remaining two patients with polyps had lymphoid hyperplasia in the ileum. All three patients who had adenomas at intraoperative small bowel enteroscopy had duodenal adenomas at esophagogastroduodenoscopy. At the age of 14 years, one patient had an intramucosal carcinoma in a small bowel juvenile polyp.Conclusion: Baseline small bowel enteroscopy should be considered at the time of surgical exploration in patients with asymptomatic familial adenomatous polyposis and juvenile polyposis. In patients with duodenal polyps, enteroscopy should be performed at the time of surgery. Biopsy and/or excision of larger polyps should be performed because these polyps may harbor a carcinoma. (Gastrointest Endosc 1995;42:560-4.) 相似文献
25.
26.
Guochuan Tsai Hsien-Yuan Lane Pinchen Yang Mian-Yoon Chong Nicholas Lange 《Neuropsychopharmacology》2004,55(5):452-456
BACKGROUND: Hypofunction of N-methyl-D-aspartate glutamate receptor had been implicated in the pathophysiology of schizophrenia. Treatment with D-serine or glycine, endogenous full agonists of the glycine site of N-methyl-D-aspartate receptor, or D-cycloserine, a partial agonist, improve the symptoms of schizophrenia. N-methylglycine (sarcosine) is an endogenous antagonist of glycine transporter-1, which potentiates glycine's action on N-methyl-D-aspartate glycine site and can have beneficial effects on schizophrenia. METHODS: Thirty-eight schizophrenic patients were enrolled in a 6-week double-blind, placebo-controlled trial of sarcosine (2 g/d), which was added to their stable antipsychotic regimens. Twenty of them received risperidone. Measures of clinical efficacy and side effects were determined every other week. RESULTS: Patient who received sarcosine treatment revealed significant improvements in their positive, negative, cognitive, and general psychiatric symptoms. Similar therapeutic effects were observed when only risperidone-treated patients were analyzed. Sarcosine was well-tolerated, and no significant side effect was noted. CONCLUSIONS: Sarcosine treatment can benefit schizophrenic patients treated by antipsychotics including risperidone. The significant improvement with the sarcosine further supports the hypothesis of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Glycine transporter-1 is a novel target for the pharmacotherapy to enhance N-methyl-D-aspartate function. 相似文献
27.
Shafi Mussa Tash Prior Nicholas Alp Kathryn Wood Keith M Channon David P Taggart 《European journal of cardio-thoracic surgery》2004,26(5):988-994
OBJECTIVE: Radial arteries are increasingly used as conduits for coronary artery bypass grafts, but perioperative graft vasospasm remains a concern. In vitro testing has demonstrated the efficacy of phenoxybenzamine and verapamil/nitroglycerin as topical antispasmodic agents, but their duration of action in vivo is unknown. Using an in vivo mouse model, we measured their duration of action in functioning vascular grafts, and compared this to their in vitro duration of action in ungrafted vascular segments. METHODS: Two millimetre mouse aortic segments (C57/BL6) were incubated with phenoxybenzamine, verapamil/nitroglycerin, or buffer (controls) for 15 min in organ chambers. Isometric tension responses to phenylephrine and prostaglandin F2alpha were measured at 0, 2, 6 and 12 h post-incubation. In parallel, 36 murine infrarenal aortic interposition grafts (2 mm) were performed. Twelve grafts were pre-treated (15 min) with phenoxybenzamine, 12 with verapamil/nitroglycerin and 12 remained untreated (controls). Isometric tension responses to the same agonists were measured in grafts harvested 2, 6, 13 and 23 h after surgery. RESULTS: Phenoxybenzamine prevented alpha-adrenergic vasoconstriction for up to 16 h in vivo (grafts), and 12h in vitro (ungrafted segments). Verapamil/nitroglycerin was effective for at least 2 h in vitro, but did not prevent vasoconstriction after 2 h in vivo. CONCLUSIONS: The mouse model appears to be a useful technique for assessing the pharmacological properties of antispasmodic agents in vivo. Phenoxybenzamine has an extended action in arterial grafts in vivo. Verapamil/nitroglycerin is short-lived in vivo but lasts longer in vitro. Measurements of antispasmodic duration of action in vitro should be interpreted with caution. 相似文献
28.
Cesar G. Victora Nubia Muoz Nicholas E. Day Lucio B. Barcelos Debora A. Peccin Noris M. Braga 《International journal of cancer. Journal international du cancer》1987,39(6):710-716
There is a cluster of high-incidence areas of oesophageal cancer in south-eastern South America, including Southern Brazil, Uruguay and parts of Argentina. The present case-control study investigated the hypothesis that this may be due to the drinking of maté, a traditional beverage drunk at a very high temperature, and also studied the role of other known risk factors such as alcohol and tobacco. Cases (171) and age- and sex-matched controls (342) were recruited from hospitals in the State of Rio Grande do Sul in Southern Brazil. The crude odds ratio for daily maté drinkers was 1.92 relative to those drinking less frequently than daily (p = 0.006). Other risk factors included the drinking of cachaça (a sugar cane spirit), smoking, rural residence, low fruit consumption and high intake of meats. After adjustment for these variables through conditional logistic regression, the odds ratio associated with daily maté drinking was reduced to 1.47 (90% CI = 0.87 - 2.50). Although the study failed to provide evidence of a strong association between maté and oesophageal cancer, the cluster of high rates could be explained by relative risks of the magnitude observed. This is due to the fact that approximately 70% of adult males and 50% of females are daily drinkers. In addition, this study revealed that alcohol, tobacco smoking and rural residence are the main risk factors for oesophageal cancer in this population and the fruit consumption confers some degree of protection. 相似文献
29.
30.
Noel R. Fajardo Filippo Cremonini Dr Nicholas J. Talley 《American Journal of Cancer》2006,5(5):319-330
In patients with cancer, constipation is a common complication. However, unlike in the general population, the impact of the symptoms of constipation on the quality of life in cancer patients is often greater. More importantly, in patients who are in the more advanced stages of the disease, constipation may also be suggestive of disease progression. Constipation as a symptom in this population is of significant importance as it may lead to life-threatening complications, i.e. bowel perforation due to fecal impaction. Therefore, in this regard, this problem deserves particular attention, as early recognition and management of complications may prevent further physical deterioration. This review aims to provide an overview of the management of constipation in patients with cancer. A symptom-based criteria definition for chronic constipation and prevalence of the problem in cancer patients provides a brief introduction. For the initial assessment and evaluation of constipation in cancer patients, an algorithm is described. The different possible etiologies of constipation in cancer patients are also discussed. Regarding therapeutic management, guidelines and recommendations for the use of different types of laxatives, stool softeners, suppositories and rectal enemas, prokinetic agents, antidepressant medications, and miscellaneous agents are succinctly discussed. Management of fecal impaction and opioid-induced bowel dysfunction are also described. Lastly, a brief overview of the management of acute colonic pseudo-obstruction and surgical or endoscopic options for large bowel obstruction are described. 相似文献